Unveiling the Power of Mitochondrial Fission and Fusion: A Five- Gene Signature for Personalized Prognosis in Gastric Cancer
The MD signature has the capacity to significantly contribute to the prediction of personalized outcomes and the advancement of novel therapeutic strategies tailored for GC patients.
Authors
- Bin Zhou (ORCID: https://orcid.org/0000-0003-3642-2048)
- Ping Tie (ORCID: https://orcid.org/0009-0008-2543-1110)
- Dongbing Li (ORCID: https://orcid.org/0000-0002-5227-9643)
- Yuanhua Liu (ORCID: https://orcid.org/0000-0001-6043-0457)
- You Lu
Institutions
- Beijing Zhongke Science and Technology (China) (CN)
- Jiangsu Cancer Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2024-10-14
- DOI
- https://doi.org/10.2174/0109298673339515240930053412
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00